Everest Biolabs Awarded $2.1 Million NIH SBIR Grant to Advance Extracellular Vesicle Biomarker Discovery at Scale with High-Purity, High-Throughput Isolation

Positive

AI Analysis

Summary

Everest Biolabs received a $2.1 million Direct-to-Phase II SBIR grant from the National Institute of General Medical Sciences to develop automated, high-throughput extracellular vesicle isolation technology for plasma biomarker discovery.

Outcome Details

Direct-to-Phase II SBIR grant awarded

Importance:4/10

Sentiment:

0.70

NIH fundingSBIR grantextracellular vesiclesbiomarkerstechnology development

Related Companies

$NHPAP

Read the original article

Published by PR Newswire Biotech on September 24, 2026 1:00 PM

Read Original